laquinimod
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Objective: To test whether Toll-like receptor (TLR) signaling plays a key role for reduced nuclear factor B (NF-κB) activation…
Laquinimod is a novel orally administered drug for the treatment of relapsing remitting multiple sclerosis (RRMS). In this…
The most significant data presented at the 28th Congress of the European Committee for Treatment and Research in Multiple…
Laquinimod is a novel, small, orally administered medication that has demonstrated efficacy in the treatment of multiple…
Introduction: MS is a chronic immunological disease of the CNS. Due to a lack of curative treatment approaches, current…
5-Chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide (laquinimod, 2) is an oral drug in clinical…